We then investigated CD39 expression in these CD8+ T populations, finding that the majority of CD8+ T cells in primary melanomas were CD39- (CD39+ mean = 20.11%, CD39- mean = 79.7%, Figure 1B). The gene discussed is ENTPD1; the disease is melanoma.